Divestment of Natural Colors to EQT closed as of March 31, 2021
Chr. Hansen Holding A/S and EQT today announced the completion of the transaction announced on September 26, 2020, whereby EQT and Chr. Hansen Holding A/S entered into an agreement with the purpose of EQT to acquire the Natural Colors division from Chr. Hansen Holding A/S.
The divestment follows the 2025 Strategy of Chr. Hansen becoming a differentiated bioscience company with focus on the microbial and fermentation technology platforms. The total consideration for the transaction is EUR 800 million on a cash and debt free basis which Chr. Hansen has already received. Transfer of business activities is completed, however, the full legal transition in a few countries will be finalized during the coming months.
The proceeds from the divestment will be used to reduce the leverage of Chr. Hansen. Also, as announced in connection with the Annual General Meeting on November 25, 2020, Chr. Hansen intends to pay out an extraordinary dividend at least equal to a normalized ordinary dividend for 2019/20, and will initiate the standard process for paying out extraordinary dividends. More information on the timing of the extraordinary dividend can be expected in connection with the Q2 announcement on April 15, 2021.
The one-off profits from the transaction, which is the difference between the book value of the transferred assets and liabilities and the transaction value received, will be accounted for as part of the profits from discontinued operations in Q3. The impact is estimated to be around EUR 650 million after taxes and transaction costs associated with the divestment.
The divestment covers business operations with asset transfers in more than 30 countries including transfer of 5 separate corporate entities and around 600 employees. Consistent with the transaction agreement, Chr. Hansen undertakes to provide various transition services for a period of up to two years to Natural Colors/EQT to ensure continuity of Natural Color business activities. The costs associated with Chr. Hansen corporate activities in Natural Colors that are not transferred to EQT will be partly covered by the fees from the transition services agreements, and will not impact the guidance on EBIT margin b.s.i. for this year.
科 汉森是一家全球性且具备差异化的生物科技公司，为食品行业、营养行业、制药行业和畜牧业开发天然原料的解决方案。 在科 汉森，我们拥有独特的优势，可通过微生物解决方案推动积极的变革。 在过去超过 150 年的时间里，我们致力于实现可持续的农业、更好的食品以及让全世界更多的人过上更健康的生活。 我们的微生物和发酵技术平台拥有改变规则的潜力，库存广泛且价值重大，包括约 40,000 种微生物菌株。 除了适应客户需求和全球趋势外，我们还将挖掘释放有益菌的力量，以应对食物浪费、全球健康以及抗生素和杀虫剂滥用等全球挑战。 作为全世界最具可持续性的生物技术公司，我们每天影响超过 10 亿人的生活。 受我们的创新传统与对前沿科学的求知驱动，公司宗旨“To grow a better world. Naturally.”体现在我们的所有工作中。